Abstract Generalised lymphatic dysplasia (GLD) is characterised by extensive peripheral lymphoedema with visceral involvement. In some cases, it presents in utero with hydrops fetalis. Autosomal dominant and recessive inheritance has been reported. A large, non-consanguineous family with three affected siblings with generalised lymphatic dysplasia is presented. One child died aged 5 months, one spontaneously miscarried at 17 weeks gestation, and the third has survived with extensive lymphoedema. All three presented with hydrops fetalis. There are seven other siblings who are clinically unaffected. Linkage analysis produced two loci on chromosome 18, covering 22 Mb and containing 150 genes, one of which is CCBE1. A homozygous cysteine to serine change in CCBE1 has been identified in the proband, in a residue that is conserved across species. High density SNP analysis revealed homozygosity (a region of 900 kb) around the locus for CCBE1 in all three affected cases. This indicates a likely ancestral mutation that is common to both parents; an example of a homozygous mutation representing Identity by Descent (IBD) in this pedigree. Recent studies in zebrafish have shown this gene to be required for lymphangiogenesis and venous sprouting and are therefore supportive of our findings. In view of the conserved nature of the cysteine, the nature of the amino acid change, the occurrence of a homozygous region around the locus, the segregation within the family, and the evidence from zebrafish, we propose that this mutation is causative for the generalised lymphatic dysplasia in this family, and may be of relevance in cases of non-immune hydrops fetalis.
Introduction
Lymphoedema is chronic, and often progressive, swelling due to failure of lymph drainage of protein-rich fluid from the interstitium, in circumstances in which capillary drainage is not increased (Mortimer 1998) . Lymphoedema can be primary or secondary (acquired). Primary lymphoedema is a chronic oedema caused by a developmental F. Connell, K. Kalidas, P. Ostergaard made equal contributions to this work, and are listed in alphabetical order. Authors in the consortium are listed in the Acknowledgements. abnormality of the lymphatic system (Mortimer 1995) . It usually affects the extremities as a result of abnormal regional lymphatic failure, although visceral lymphatic drainage can also be impaired. The accumulation of fluid in the interstitial spaces occurs due to an anatomical or functional defect in the lymphatic vessels. Impairment of the lymphatic drainage system can occur as a non-syndromic Mendelian condition or as part of a more complex syndromic disorder (Ferrell et al. 2008) .
Lymphoedema can be debilitating and disfiguring. It causes physical and psychological morbidity, and in some cases can be life-threatening. The burden of this disease and its complications is considerable. Treatment options are limited and only palliative.
In recent years, there has been considerable progress made in the understanding of the molecular pathways underlying lymphangiogenesis, with mouse knockouts uncovering a range of gene products, from the master switch, PROX1 (Wigle and Oliver 1999) , through to the guidance molecules Ephrin B4 and ephrin B2 (Makinen et al. 2005 ; for review see Tammela et al. 2005) . In humans, only three causative genes have been identified for disorders where lymphoedema is the primary phenotype; VEGFR3 in Milroy disease [Ferrell et al. 1998; Karkkainen et al. 2000; Irrthum et al. 2000) ; FOXC2 for Lymphoedema distichiasis (Fang et al. 2000; Bell et al. 2001; Erickson et al. 2001; Brice et al. 2002) ] and mutations in SOX18 are responsible for causing the rare syndrome, hypotrichosislymphoedema-telangiectasia (Irrthum et al. 2003) . There are many other forms of primary lymphoedema where the genetic cause is unknown and the phenotype not well delineated. Widespread peripheral lymphoedema associated with systemic involvement is termed generalised lymphatic dysplasia (GLD). It can be present in utero with ascites, pleural/pericardial effusions and hydrops fetalis. In 1989, Hennekam et al. described an autosomal recessive condition in which members of a consanguineous family were reported with congenital severe peripheral lymphoedema, intestinal lymphangiectasia, facial anomalies, seizures, mild growth retardation and mental retardation (Hennekam et al. 1989) . The phenotype of Hennekam syndrome has since been expanded and the degree of mental retardation is reported to be very variable, even within families, ranging from near normal development to severe delay (Forzano et al. 2002; Van Balkom et al. 2002; Yasunaga et al. 1993) . The generalised lymphatic maldevelopment that characterises this syndrome predominantly affects the limbs and bowel, but can also manifest in the face, genitalia and other organs (pleura, pericardium, thyroid and kidneys) (Forzano et al. 2002; Van Balkom et al. 2002) . The lymphoedema is usually congenital, can be asymmetrical and, often, gradually progressive (Van Balkom et al. 2002) . Additional features include, congenital heart defects, vascular anomalies, craniosynostosis, congenital glaucoma, polysplenia, ear anomalies, hearing loss, primary hypothyroidism, pyloric stenosis, camptodactyly, rectal prolapse and renal malformations (Al-Gazali et al. 2003; Angle and Hersh 1997; CormierDaire et al. 1995; Scarcella et al. 2000; Van Balkom et al. 2002) . A genetic cause of Hennekam syndrome has yet to be identified, and there may well be genetic heterogeneity for this syndrome, but it is families such as the one described in this report (see below) that may lead to further insight into this syndrome and clarification of the spectrum of the phenotype of this rare condition.
A family with non-consanguineous parents, seven unaffected children and three offspring affected with a generalised lymphatic dysplasia, has been ascertained and genetically investigated. The proband has extensive lymphoedema of all parts of the body, and DNA was available from the two other affected siblings, both deceased. Linkage analysis identified two loci on chromosome 18, with 150 genes within them. Sequence analysis of these genes was undertaken.
Family profile
The family was ascertained via the joint lymphoedema/ genetic clinic at St George's Hospital, London, UK. The proband, II3, (Fig. 1) is the child of non-consanguineous parents. Antenatal hydrops, with pleural effusions and ascites, was diagnosed at 16-weeks gestation. The increasing ascites and polyhydramnios required drainage via a peritoneal shunt at 33-weeks gestation. The antenatal karyotype result was 46 XX (confirmed postnatally) and fetal echocardiogram was normal.
The proband was born at 35 weeks gestation weighing 3.8 kg. At birth, she was oedematous and was admitted to the neonatal unit requiring ventilation and inotropic support. Her albumin following birth was 18 g/L (normal range 35-48 g/L) and she received regular albumin infusions. Liver function was otherwise normal. She had an enlarged clitoral glans but urinary sex hormone profiles, a short synacthen test, and metabolic profile were all normal. After commencing medium chain triglyceride (MCT) enteral nutrition at the age of 32 days, she developed severe diarrhoea. Bowel biopsies taken at 7 weeks of age did not reveal evidence of intestinal lymphangiectasia but subsequent bowel histology showed evidence of lymphatic dilatation and inflammation. She continued on a treatment regime of albumin infusions and total parenteral nutrition. At this time she had severe peripheral oedema affecting the legs, feet, arms, hands and face (including conjunctiva). At the age of 3 months she developed a severe stridor. Laryngotracheobronchoscopy showed a narrowed trachea, compression of the trachea by oedema and pulmonary hypoplasia. Respiratory difficulties secondary to upper respiratory tract obstruction and reduced lung volume were ongoing in the first year of life. Age 6 years, she continues to have widespread, generalised lymphoedema, affecting the whole body (see Fig. 2 ). Recurrent ascites is an ongoing problem, for which varying treatments have been tried, including albumin infusions, diuretics (spironolactone) and octreotide infusions. Her serum albumin is persistently low (approximately 19 g/L). She is kept on an MCT diet as treatment for intestinal lymphangiectasia. Manual lymphatic drainage and multi-layer bandaging techniques have been used to try and reduce the peripheral oedema. She has dysmorphic facies consistent with past in utero oedema (epicanthic folds, depressed nasal bridge) and ongoing facial lymphoedema. Her development has been essentially normal, allowing for some delay in achieving early developmental milestones given the severity of her ongoing illness. She continues on thyroxine treatment for hypothyroidism.
Male infant (II.1 Fig. 1 ) was born at 29-weeks gestation with a birth weight of 2.78 kg. Hydrops was observed on the 20-week gestation ultrasound scan. The pregnancy was further complicated by polyhydramnios. An antenatal echocardiogram was normal but postnatally he developed hypertrophic cardiomyopathy. He was oedematous at birth (normal serum albumin), with chylous ascites and chylous pleural effusions, and had severe pulmonary hypoplasia with pulmonary lymphangiectasia. Oral feeding could not be established. He died at the age of 5 months having never been discharged from the neonatal unit. No post mortem was carried out. The differential diagnoses in this infant included Noonan syndrome as hydrops and hypertrophic Fig. 1 Haplotypes showing the delineation of the two loci using microsatellites. The positions of the 33 markers shown (a proportion of those used in the analysis) are given in Table 1 . The two linkage intervals are given by the two sets of parallel lines. The position of CCBE1 is indicated by an arrow Fig. 2 The proband, showing her extensive and generalised lympoedema Hum Genet (2010) 127:231-241 233 cardiomyopathy are associated with this diagnosis. However, the subsequent family history and phenotype in the other two affected family members made this diagnosis unlikely. Male infant (II.2 Fig. 1 )-an ultrasound scan of this fetus at 16/40 weeks gestation revealed hydrops fetalis. The pregnancy spontaneously miscarried at 17-weeks gestation. A post mortem examination showed severe nonimmune hydrops, with normal heart and lungs, and no other structural abnormalities reported. There were 4 ml of blood stained ascitic fluid in the peritoneal cavity, and 2 ml straw coloured fluid in the pleural cavities. Infective causes of hydrops were ruled out, and lysosomal enzymes were normal, making storage diseases unlikely.
The occurrence of three pregnancies (two male and one female) affected by hydrops, with no other family history, is suggestive of autosomal recessive inheritance of a generalised lymphatic dysplasia (GLD).
Methods

SNP chip array and linkage analysis
DNA was extracted from peripheral blood using a standard chloroform ethanol procedure. There was no blood available from the fetus or baby that died, and DNA was taken from tissue samples in these cases. The linkage SNP microarray analysis was performed at the Institute of Child Health, London, using standard procedures, with an Affymetrix 10K SNP-chip (Xba142 with 10,204 SNPs). Processing of arrays was performed according to the manufacturer's protocol and call rates were all above 99%. All genotypes were checked for Mendelian inconsistencies in MERLIN. A parametric linkage test was run in MERLIN (Abecasis et al. 2002) using an autosomal recessive model. Microsatellite and polyacrylamide gel electrophoresis were used to confirm and refine the two regions. This work resulted in a final list of 150 genes which were prioritised according to their functional relevance. DNA from the three affected individuals was hybridised on a 250 k Affymetrix SNP chip (Part number 900767; 262,000 SNPs) at Gene Service, Nottingham, following the manufacturer's protocol. Homozygous regions on chromosome 18 shared by the 3 affected siblings were investigated using Exclude AR (Woods et al. 2004 ).
Gene sequencing
Primers for candidate genes were designed using the Primer3 software (Rozen and Skaletsky 2000) . CCBE1 has 11 exons, and primer sequences and PCR programmes are available on request. The cleaned PCR products were sequenced using BigDye Terminator v3.1 and an ABI 3130xl Genetic Analyzer. The sequencing traces were visually inspected in Chromas Lite (Technelysium Pty Ltd) and finally compared to wild type sequence using CLC Sequence Viewer 6.2 (CLC bio A/S). As no restriction site was found for the SNP in exon 3, 200 controls (caucasian) were sequenced. Primers for exon 3 which produced allele dropout were: 3F-AATGTTTCCTGGGCACAAGT; 3R-AAGACCTATATTCCATGAACATCTGA whilst those where amplification was successful were: 3aF ACTTCA CCCCTACTTTGCTTT; 3cR AGGGAGGAGGGTTGGT TCT
Mutation database analysis
The change found in CCBE1 was examined for potential effect on the protein using SIFT (http://sift.jcvi.org) and PolyPhen (http://genetics.bwh.harvard.edu/pph/).
RNA analysis
Blood was taken from the mother using a PAXgene Blood RNA tube (PreAnalytiX). RNA was purified following the manufacturer's protocol, the quality was checked on Nanodrop. cDNA was obtained using SuperScript II Reverse transcriptase (Invitrogen). A skin biopsy was also taken from the mother, stored in RNALater (Ambion) for 48 h in a refrigerator, and then RNA was extracted using the same protocol as for the blood sample. Primers were designed to check for the presence of an RNA transcript from CCBE1 in the two tissues using Primer3 software and are available upon request. Control primers for GAPDH were used to check the cDNA.
Results
Using random markers in a genome wide analysis, the family was only large enough to generate a LOD score of 2.4, so could not reach the conventionally significant LOD score of 3. The severity of the phenotype meant that the chance of the clinically unaffected siblings carrying the affected genotype was remote, although it had to be considered. Linkage analysis was carried out on the data from a 10-kb Affymetrix SNP chip, using MERLIN. This produced two loci on chromosome 18; one at 18p and one at 18q (Fig. 3 ). These both gave LOD scores of 2.4. The remainder of the genome gave no loci returning a positive LOD score.
The spacing and informativity of the SNPs meant that microsatellite mapping was needed to refine the two intervals (see Fig. 1 and Table 1 ). The two regions shared by the three affected siblings were large, (approximately 17 Mb for the interval on the p arm and 15 Mb for that on the q arm), but shared haplotypes in II.9 and II.10 and affected siblings reduced the 18p interval to 7 Mb. The region on 18q could not be further reduced.
Database mining of the intervals using NIBSC (http://ncbi.nlm.nih.gov/sites/entrez), Ensembl (http:// ensemble.org) and UCSC (http://genome.ucsc.edu) produced the current knowledge for all genes in the intervals. Those candidates considered 'Good' or 'Average' on the basis of their biochemistry, function and distribution, are shown in Table 2 . Sequencing of all the 'Good' candidates yielded no mutations, but in the 'Average' group was CCBE1, which had a suggested role in calcium transport, or an EGF binding function, based on homology to other proteins. Sequence analysis identified an apparently homozygous mutation in the proband and her two affected siblings, changing a cysteine to a serine (Fig. 4) . The change is p.Cys75Ser (c.223T[A). This residue is conserved across species, being present in 37 of the 40 species represented in the Ensembl homologue database (see Table 3 ). In the three in which it was not present; stickleback, medaka and platypus, there was no equivalent residue. The PolyPhen database indicates this as a probably damaging mutation, and SIFT predicts that the change will affect protein function. Recently, ccbe1 was reported to have an 'indispensable role in lymphangiogenesis' by Hogan et al. (2009) in the zebrafish. The approximate position of CCBE1 in the 18q linkage interval is shown in Fig. 1 .
Familial DNA analysis using the first primer set indicated heterozygosity in the paternal haplotype but both maternal alleles were apparently T. However, it was determined that the penultimate base of the reverse primer contained a SNP (found in intron 3) resulting in nonamplification of one of the mother's alleles (see ''Methods'' for primer details). Primers were therefore redesigned to span the mutation and the SNP (see ''Methods''), and results using the second primer set showed that there was indeed both heterozygosity for the SNP and for the mutation in the mother (mutation shown in Fig. 5 ). All members of the family were sequenced with the new primer set, and this produced the result that was expected from the haplotype data; both parents were heterozygous for p.Cys75-Ser, and all three affected siblings were homozygous. Individuals II.4, II.7, II.9 and II.10 were heterozygous, and II.5, II.6 and II.8 were homozygous wildtype. This change was not found in 400 control chromosomes.
The occurrence of the same mutation in unrelated parents prompted investigation into the possibility that this homozygosity might be more extensive than simply this one base, and analysis of chromosome 18 in the three affected individuals, with a 250 k genomic SNP chip, produced an area of homozygosity of about 900 kb. A heterozygous SNP at rs4349256 (54,834,349 base position) delineated the upper boundary of homozygosity. Fig. 1 The positions are for build 36.3 on NCBI Mapviewer There was another heterozygous SNP at rs4940912 (55, 732, 132) . This region of shared homozygosity contained CCBE1 (55,250,000-55,513,000).
As very little is known about the expression of CCBE1, we investigated its transcription in lymphocytes and skin from the mother of the proband. If the transcript was produced it would also allow confirmation of the mutant residue in the RNA. cDNA was successfully produced from both white cells and skin, and GAPDH amplified in both. However, no product at all was obtained for CCBE1 from lymphocytes, but a strong signal was given by the skin RNA (Fig. 6) . Sequencing of this product showed that both alleles were expressed (data not shown).
Discussion
A homozygous mutation in the CCBE1 gene has been identified in three siblings affected by generalised lymphatic dysplasia (GLD). The phenotype is severe, causing significant morbidity and mortality in this family. Examination of chromosome 18q in the affected individuals in the pedigree has shown that they all share a homozygous region around CCBE1 of just under a megabase. This is strongly suggestive of a previously unknown distant relationship between the parents, and Identity by Descent (IBD) of the mutation in this family.
Ccbe1 has very recently been shown to be essential for the development of the lymphatics in zebrafish (Hogan et al. 2009 ). Prior to this little was known about the function of this gene. Indeed, its name; Collagen and Calcium Binding EGF domain 1, derives from the fact that there are elements within the protein that show resemblance to other known protein family domains, rather than any knowledge of its particular function (see Fig. 7 ). The zebrafish mutant full of fluid (fof), which was produced by mutagenesis, was found to have a homozygous mutation in exon 4 of the ccbe1 gene (Hogan et al. 2009 ). This led to an absence of the thoracic duct and longitudinal lymphatic vessels, and such severe oedema that only 3 of 28 embryos survived to 36 days post fertilisation. As ccbe1 was not expressed in lymphatic tissue, but seemed to be found in the routes where lymphatics were developing, it was proposed that it might act as part of the guidance system for Fig. 4 Sequencing traces for exon 3 showing the heterozygous allele in the father, apparent homozygosity for the wildtype T allele in the mother, and homozygous A in the affected child budding lymphatics in rather the same way that ephrin B2 and ephrin B4 have been suggested to be involved in such a process in mice (Makinen et al. 2005) .
The mutation in the zebrafish causes a change of aspartic acid to glutamic acid at residue 162. This is a change in size of R group but is otherwise non-conservative. The amino acid is conserved across species, however, with the exception of the cat where there is no equivalent residue. The base change in our report is in a more Nterminal part of the molecule; the function of which is currently unknown. The exon structure of the gene, the cysteine residues, and the two proposed domains that show similarity to known protein superfamilies are shown in Fig. 7 . The suggested homology for a stretch of CCBE1 from amino acid 71-219 with the growth factor domain superfamily is indicated in Fig. 7 , and contains the cysteine that is mutated in the patients reported here. This cysteine rich region is found in a number of proteins that have an involvement in signal transduction by receptor tyrosine kinases. Insulin growth factor binding protein (IGFBP) is a member of this family, and controls the distribution, function and activity of insulin-like growth factors I and II, which are key regulators of cell proliferation. The highest conservation of IGFBPs is in the N-terminal Cys-rich IGFbinding domain, where there are 10-12 conserved cysteine 
Of the 43 orthologues in Ensembl, this amino acid was not present only in those cases (platypus, cat and medaka) where there was no equivalent residue in the molecule Fig. 5 Sequence of exon 3 for the mother (I.1) using the second primers set, showing heterozygosity for the mutation Fig. 6 cDNA from mother (I.1) amplified with two sets of primers for CCBE1 and run on an agarose gel. Lane 1 is a 100-kb ladder. Lanes 2 and 7 are negative controls. Lanes 3-6 are amplicons from primers in exons 1 and 6 (480 bp product). 3 and 6 are from skin biopsy of I.1, 4 is from lymphocytes of I.1, 5 is a control skin biopsy. Lanes 8-11 are amplified with primers from exons 1 and 11 (960 bp product). Lanes 8 and 11 are from skin biopsy of I.1, Lane 9 is from lymphocytes of I.1, Lane 10 is a control skin biopsy residues. If CCBE1 is involved with guidance and lymphatic proliferation, it is quite likely that production of local growth factors would be essential for this process. The cysteine to serine change seen in this family is significant, as cysteine residues are often involved in inter or intramolecular disulfide bond formation. This residue is highly conserved, and is only absent in 3 of 41 species, where there is not an equivalent amino acid in the orthologue. We wanted to look at two reasonably readily available sources of protein and RNA, namely blood and skin. Nagase et al. (2001) who cloned the cDNA, showed tissue expression in adult lung, liver and kidney, while Hogan et al. (2009) showed that there was no expression in adults in epithelial cells or blood. Our cDNA data confirms that there is no expression in lymphocytes, but shows a transcript from skin RNA. This could be a potentially useful finding for examination of mutant transcript and protein.
Future analysis of other patients with a similar widespread generalised lymphatic dysplasia, and with a family history of hydrops fetalis, for mutations in CCBE1 is clearly a priority.
In summary, a mutation of a highly conserved cysteine residue in exon 3 of CCBE1 has been identified in three siblings with an autosomal recessive generalised lymphatic dysplasia. The homozygous nature of the mutation, the strong likelihood of IBD in the family, and the data from zebrafish, make it likely that this change is pathogenic. This is the first gene in which mutations cause extensive generalised lymphoedema in humans, rather than the peripheral disease associated with the currently known genes, VEGFR3 and FOXC2. The identification of such a gene underscores the validity of human genetic approaches to identifying disease causing mutations and the utility of the zebrafish in this context. The phenotype is extremely severe, and can be lethal, and investigations into the function and nature of action of the gene product in humans may well have implications in understanding the nature of non-immune hydrops fetalis, and in the longer term the possibility of in utero therapy for this important and currently ill understood condition. 1 3 2 4 5 6 7 11 8 Fig. 7 Schematic of CCBE1, indicating the 11 exons in the top line, the position of the cysteine residues on the second line, and two regions of homology with other protein Super Families (GFRD Growth Factor Receptor Domain, EGF EGF binding domain). The arrow indicates the exon containing the p.Cys75Ser mutation
